PPCB · Propanc Biopharma, Inc. · Analyst Estimates
$1.99
+0.07 (+3.65%)
At close · Nov 13
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 25, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-K filed Sep 25, 2026
Market Cap
$1.22M
Shares
633,112
Volume · Nov 12
21.9K
Avg daily vol (14 sessions)
35.67K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Propanc Biopharma, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 06:17 UTC · Publication dates shown per estimate · 1 metric / period groups
FY ending 2016-06-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|